Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD). In general, the outcome of drug-eluting stent (DES) placement has a proven efficacy in randomized trials. However, the difference in...

Descripción completa

Detalles Bibliográficos
Autores principales: Çiçek, Davran, Pekdemir, Hasan, Haberal, Cevahir, Kalay, Nihat, Binici, Süleyman, Altay, Hakan, Müderrisoğlu, Haldun
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020394/
https://www.ncbi.nlm.nih.gov/pubmed/21234271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020394/
https://www.ncbi.nlm.nih.gov/pubmed/21234271

Ejemplares similares